PTGX logo

Protagonist Therapeutics (PTGX) Total Expenses

Annual Total Expenses

$153.65 M
-$4.30 M-2.72%

31 December 2023

PTGX Total Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Expenses

$46.13 M
+$3.17 M+7.37%

30 September 2024

PTGX Quarterly Total Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PTGX Total Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-+24.8%
3 y3 years+0.3%+1.1%
5 y5 years+90.3%+130.4%

PTGX Total Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-2.7%+0.3%-5.2%+42.8%
5 y5 years-2.7%+90.3%-5.2%+130.4%
alltimeall time-2.7%+1548.8%-5.2%+1615.4%

Protagonist Therapeutics Total Expenses History

DateAnnualQuarterly
Sept 2024
-
$46.13 M(+7.4%)
June 2024
-
$42.96 M(-11.7%)
Mar 2024
-
$48.64 M(+31.6%)
Dec 2023
$153.65 M(-2.7%)
$36.95 M(-3.6%)
Sept 2023
-
$38.33 M(-9.5%)
June 2023
-
$42.35 M(+17.6%)
Mar 2023
-
$36.02 M(-1.4%)
Dec 2022
$157.95 M(+3.1%)
$36.52 M(+13.0%)
Sept 2022
-
$32.30 M(-23.6%)
June 2022
-
$42.30 M(-9.7%)
Mar 2022
-
$46.83 M(+2.6%)
Dec 2021
$153.20 M(+64.5%)
$45.63 M(+3.2%)
Sept 2021
-
$44.21 M(+33.4%)
June 2021
-
$33.15 M(+9.7%)
Mar 2021
-
$30.21 M(+23.4%)
Dec 2020
$93.14 M(+15.3%)
$24.48 M(+17.2%)
Sept 2020
-
$20.89 M(-14.5%)
June 2020
-
$24.43 M(+4.7%)
Mar 2020
-
$23.34 M(+16.6%)
Dec 2019
$80.75 M
$20.02 M(-6.1%)
DateAnnualQuarterly
Sept 2019
-
$21.31 M(-8.2%)
June 2019
-
$23.22 M(+43.3%)
Mar 2019
-
$16.21 M(-8.8%)
Dec 2018
$73.19 M(+26.3%)
$17.77 M(+14.6%)
Sept 2018
-
$15.51 M(-25.9%)
June 2018
-
$20.91 M(+10.0%)
Mar 2018
-
$19.01 M(+28.5%)
Dec 2017
$57.96 M(+77.4%)
$14.79 M(+7.5%)
Sept 2017
-
$13.76 M(-9.1%)
June 2017
-
$15.13 M(+6.0%)
Mar 2017
-
$14.27 M(+25.2%)
Dec 2016
$32.67 M(+120.8%)
$11.40 M(+59.7%)
Sept 2016
-
$7.14 M(+0.7%)
June 2016
-
$7.09 M(+0.7%)
Mar 2016
-
$7.04 M(+40.8%)
Dec 2015
$14.79 M(+58.8%)
$5.00 M(+24.4%)
Sept 2015
-
$4.02 M(+30.4%)
June 2015
-
$3.08 M(+14.7%)
Mar 2015
-
$2.69 M
Dec 2014
$9.32 M
-

FAQ

  • What is Protagonist Therapeutics annual total expenses?
  • What is the all time high annual total expenses for Protagonist Therapeutics?
  • What is Protagonist Therapeutics quarterly total expenses?
  • What is the all time high quarterly total expenses for Protagonist Therapeutics?
  • What is Protagonist Therapeutics quarterly total expenses year-on-year change?

What is Protagonist Therapeutics annual total expenses?

The current annual total expenses of PTGX is $153.65 M

What is the all time high annual total expenses for Protagonist Therapeutics?

Protagonist Therapeutics all-time high annual total expenses is $157.95 M

What is Protagonist Therapeutics quarterly total expenses?

The current quarterly total expenses of PTGX is $46.13 M

What is the all time high quarterly total expenses for Protagonist Therapeutics?

Protagonist Therapeutics all-time high quarterly total expenses is $48.64 M

What is Protagonist Therapeutics quarterly total expenses year-on-year change?

Over the past year, PTGX quarterly total expenses has changed by +$9.18 M (+24.84%)